483
Continental Services Group, Inc.Continental Services Group, Inc. – FDA 483, Apr 30, 2026
Record Details
An FDA inspection of Continental Services Group, Inc., a blood bank in Ft Lauderdale, FL, revealed two significant observations. The firm failed to adequately investigate and follow up on severe donor reactions, and also failed to properly store and segregate expired supplies, creating a risk of inadvertent use in blood collection and processing operations.
View Company Profile
ID · 30114164-3de6-4925-affb-edfabea9cc49
Other documents for Continental Services Group, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.